JPRN-UMIN000004170招募中未知
Feasibility study of PET Imaging with 64Cu-DOTA-trastuzumab in HER2 positive breast cancer - PET Imaging with Cu-64 Labeled Trastuzumab
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •8. 1.active concomitant malignancy 2.congestive heart failure (CHF)3.uncontrolled angina pectoris, arrhythmia 4.symptomatic infectious disease 5.severe bleeding 6.pulmonary fibrosis 7.obstructive bowel disease or severe diarrhea 8.symptomatic peripheral or cardiac effusion 9.symptomatic brain metastasis.
研究者
相似试验
招募中
不适用
tility study of PET imaging with 64Cu-DOTA labeled antibody probes against HER2 and EGFRBreast cancer, Gastric cancer, Colorectal cancer, GliomaJPRN-UMIN000017446ational Cancer Center Hospital200
进行中（未招募）
1 期
Combined 64Cu-DOTATATE and 18F-FDG PET/CT Imaging in Patients with Neuroendocrine Tumorseuroendocrine neoplasmsMedDRA version: 21.0Level: LLTClassification code 10062476Term: Neuroendocrine tumorSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10057270Term: Neuroendocrine carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: LLTClassification code 10068916Term: Pancreatic neuroendocrine tumor metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10071542Term: Neuroendocrine carcinoma metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10077560Term: Gastroenteropancreatic neuroendocrine tumor diseaseSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: LLTClassification code 10067518Term: Pancreatic neuroendocrine tumorSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 24.1Level: LLTClassification code 10085846Term: Duodenal neuroendocrine tumorSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 24.1Level: LLTClassification code 10085958Term: Small intestine neuroendocrine tumorSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2021-005919-30-DKDepartment of Clinical Physiology and Nuclear Medicine, Rigshospitalet200
招募中
不适用
PET imaging of breast cancer using 64Cu-DOTA-Trastuzumab for evaluating HER2 expression: Investigator Initiated TrialsKCT0002791Korea Cancer Center Hospital30
招募中
1 期
Evaluation of CCR2 in Patients Post Myocardial InfarctionHeart DiseasesNCT05107596Washington University School of Medicine90
未知
不适用
64Cu-DOTA-nivolumab PET imaging in patients with malignant melanoma or non-small cell lung cancer.nresectable or metastatic malignant melanoma,unresectable or metastatic non small cell lung cancerJPRN-UMIN000026658ational Cancer Center Hospital, Tokyo, Japan50